Researchers create efficient semisynthesis of biopharmaceutic-Fc conjugates

Researchers report on biopharmaceutic-Fc conjugates
Biopharmaceutic-Fc conjugate synthesized by our method possessed a long half-life inside the body. Credit: University of Electro Communications

Biopharmaceutics consisting of middle molecules, for example, peptide or nucleic-acid aptamers, have been attracting attention as promising molecular modalities in current drug discovery.

A major problem of such pharmaceutics for therapeutic applications is that the half-lives of their circulating plasma inside the body are too short. Ideally, a precise conjugation of the Fc fragment of human antibodies with pharmaceutics would extend the half-lives. Practically, the conjugation between the complicated molecules is still immature.

Now, Masumi Taki and colleagues at the University of Electro-Communications (UEC), and Ajinomoto Co. Inc. have established a facile and efficient semisynthesis method to obtain biopharmaceutics-Fc conjugates.

A combination of chemoenzymatic novel reaction (i.e., the NEXT-A reaction) followed by well-known yielded almost 100% ; and the N-terminal specific precise conjugation of the Fc fragment with different kinds of biopharmaceutics was unambiguously identified by several methods including deconvoluted .

A Fc-conjugated (peptidic) pharmaceutic synthesized by this method led to a long-circulating plasma half-life inside mice while retaining its original biological activity.

The Fc-conjugation platform described can be applied many kinds of biopharmaceutics with different molecular modalities.

Explore further

Scientists develop method to quickly enhance immune-system proteins

More information: Shigeo Hirasawa et al. Facile and Efficient Chemoenzymatic Semisynthesis of Fc-Fusion Compounds for Half-Life Extension of Pharmaceutical Components, Bioconjugate Chemistry (2019). DOI: 10.1021/acs.bioconjchem.9b00235
Journal information: Bioconjugate Chemistry

Citation: Researchers create efficient semisynthesis of biopharmaceutic-Fc conjugates (2019, September 11) retrieved 15 September 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more